Department of Cardiology and Internal Diseases, Military Institute of Medicine, Szaserów Street 128, 04-141 Warsaw 44, Poland.
Department of Bioinformatics, Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland.
Biomed Res Int. 2014;2014:462609. doi: 10.1155/2014/462609. Epub 2014 Oct 20.
Brugada Syndrome (BS) is an inherited channelopathy associated with a high incidence of sudden cardiac death. The paper presents the discovery of new genetic variants of SCN5A gene which might be associated with the development of a concealed form of Brugada Syndrome. The study involved a group of 59 patients (37 men) with suspected concealed form of Brugada Syndrome. Pharmacological provocation with intravenous ajmaline administration was performed. Six patients with positive test results were subjected to molecular analysis of SCN5A gene with MSSCP method. Additionally, MSSCP genotyping was performed for samples obtained from the family members with Brugada Syndrome, despite the fact that they had negative ajmaline challenge test results. Genetic examinations of the SCN5A gene at 6 positive patients showed 6 known polymorphisms, 8 new single nucleotide point (SNP) variants located at exons, and 12 new single nucleotide point variants located at introns. Among new SNPs localized in SCN5A gene exons three SNPs affected the protein sequence.
Brugada 综合征(BS)是一种与高发生率的心脏性猝死相关的遗传性离子通道病。本文介绍了 SCN5A 基因突变的新发现,这些突变可能与 Brugada 综合征隐匿型的发生有关。该研究纳入了 59 名疑似 Brugada 综合征隐匿型的患者(37 名男性)。通过静脉注射阿马林进行药物激发试验。对 6 名阳性试验结果的患者进行 SCN5A 基因的 MSSCP 方法的分子分析。此外,对有 Brugada 综合征家族史但阿马林激发试验结果为阴性的患者样本进行 MSSCP 基因分型。在 6 名阳性患者的 SCN5A 基因检查中发现 6 个已知的多态性,8 个新的位于外显子的单核苷酸点(SNP)变异,以及 12 个位于内含子的新的单核苷酸点变异。在外显子中定位的新 SNP 中有 3 个 SNP 影响了蛋白质序列。